JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joseph Alex
Alex R.J. Cale
Steven C. Griffin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alex, J.
Right arrow Articles by Griffin, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alex, J.
Right arrow Articles by Griffin, S. C.
Related Collections
Right arrow Cerebral protection
Right arrow Coronary disease
Right arrow Extracorporeal circulation

J Thorac Cardiovasc Surg 2005;130:1623-1630
© 2005 The American Association for Thoracic Surgery

Evolving Technology

Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomized double-blind trial

Joseph Alex, MD, MRCS a , * , Gerard Laden, BSc b , Alex R.J. Cale, MD, FRCS a , Sean Bennett, MD, FRCA c , Kenneth Flowers, BSc, PhD d , Leigh Madden, BSc, PhD e , Eric Gardiner, BSc, PhD f , Peter T. McCollum, MD, FRCS, PhD g , Steven C. Griffin, MD, FRCS c

a Department of Cardiothoracic Surgery, Castle Hill Hospital
b Hyperbaric Unit, BUPA Hospital, Hull and East Riding
c Department of Cardiothoracic Anaesthesia, Castle Hill Hospital
d Department of Neuropsychology, University of Hull
e Department of Immunology, University of Hull
f Department of Statistics, University of Hull
g Academic Department of Surgery, University of Hull, Hull, United Kingdom

Read at the Eighty-fifth Annual Meeting of The American Association for Thoracic Surgery, San Francisco, Calif, April 10-13, 2005.

* Address for reprints: Joseph Alex, MD, MRCS, The Cottage, Main Road, Covenham St Bartholomew, Louth, LN11 0PF, UK (Email: mrjosephalex{at}yahoo.co.uk).

OBJECTIVE: Animal studies have shown that pretreatment with hyperbaric oxygen can induce central nervous system ischemic tolerance and also modulate the inflammatory response. We evaluated this therapy in patients undergoing cardiopulmonary bypass.

METHODS: Sixty-four patients were prospectively randomized to group A (n = 31; atmospheric air, 1.5 atmospheres absolute) or group B (n = 33; hyperbaric oxygen, 2.4 atmospheres absolute) before on-pump coronary artery bypass grafting. Age, sex, body mass index, diabetes, hypertension, smoking, coronary disease severity, left ventricular function, Parsonnet score, Euroscore, bypass time, myocardial ischemia time, and number of grafts were comparable in both groups. Canadian Cardiovascular Society angina, New York Heart Association dyspnea, and previous myocardial infarction were significantly higher in group B. Inflammatory markers were analyzed before surgery and 2 and 24 hours after bypass. Neuropsychometric testing was performed 48 hours before surgery and 4 months after surgery and included trail making A and B, the Rey auditory verbal learning test, grooved peg board, information processing table A, and digit span forward and backward. Neuropsychometric dysfunction was defined as more than 1 SD deterioration in more than 2 neuropsychometric tests. Chi-square tests, Fisher tests, t tests, and analysis of variance were used as appropriate for statistical analysis.

RESULTS: Group A had a significant postoperative increase in the inflammatory markers soluble E-selectin, CD18, and heat shock protein 70. This was not observed in group B. Neuropsychometric dysfunction was also significantly higher in group A compared with group B. There was no difference in any other early postoperative clinical outcome.

CONCLUSIONS: Our results seem to indicate that pretreatment with hyperbaric oxygen can reduce neuropsychometric dysfunction and also modulate the inflammatory response after cardiopulmonary bypass. However, further multicenter randomized trials are needed to clinically evaluate this form of therapy.

Abbreviations and Acronyms ATA = atmospheres absolute; HADS = hospital anxiety and depression scale; HSP = heat shock protein; ICAM = intercellular adhesion molecule; IL = interleukin; TNF = tumor necrosis factor; sE-selectin = soluble E-selectin; sP-selectin = soluble P-selectin




This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
S. R. Thom
Oxidative stress is fundamental to hyperbaric oxygen therapy
J Appl Physiol, March 1, 2009; 106(3): 988 - 995.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. R. Thom, V. M. Bhopale, D. J. Mancini, and T. N. Milovanova
Actin S-Nitrosylation Inhibits Neutrophil {beta}2 Integrin Function
J. Biol. Chem., April 18, 2008; 283(16): 10822 - 10834.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.